Erratum: Sialic acid metabolic engineering: A potential strategy for the neuroblastoma therapy (PLoS ONE (2014) 9:8 (e105403) DOI: 10.1371/journal.pone.0105403);Sialic acid metabolic engineering: A potential strategy for the neuroblastoma therapy

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Gnanapragassam, Vinayaga S ^a   Bork, Kaya ^a   Galuska, Christina E ^b   Galuska, Sebastian P ^b   Glanz, Dagobert ^a   Nagasundaram, Manimozhi ^a   Bache, Matthias ^c   Vordermark, Dirk ^c   Kohla, Guido ^d   Kannicht, Christoph ^d   Schauer, Roland ^e   Horstkorte, Rüdiger ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d Octapharma RandD   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; N PENTANOYL MANNOSAMINE; N PROPANOYL MANNOSAMINE; POLYSIALIC ACID; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG; HEXOSAMINE; N ACETYLNEURAMINIC ACID; N-PANTANOYLMANNOSAMINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CELL INVASION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG DETERMINATION; DRUG SENSITIVITY; DRUG TARGETING; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; METABOLIC ENGINEERING; METABOLIC SIA ENGINEERING; METASTASIS INHIBITION; NEUROBLASTOMA; NEUROBLASTOMA CELL; SIALYLATION; STRATEGIC PLANNING; ANALOGS AND DERIVATIVES; CELL MEMBRANE; CELL MOTION; CHEMISTRY; DRUG EFFECTS; METABOLISM; MULTIDRUG RESISTANCE; RADIATION DOSE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; HEXOSAMINES; HUMANS; METABOLIC ENGINEERING; N-ACETYLNEURAMINIC ACID; NEUROBLASTOMA; RADIATION TOLERANCE; SIALIC ACIDS;

EID: 84923881125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154289     Document Type: Erratum

References (33)

1. Schauer R (2009) Sialic acids as regulators of molecular and cellular interactions. Curr Opin Struct Biol 19: 507-514. doi: 10.1016/j.sbi.2009.06.003.
2. Varki A, Schauer R (2009) Sialic Acids. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, et al. (editors) Essentials of Glycobiology, 2nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (NY) pp 1099-1217.
3. Sato C, Kitajima K (2013) Disialic, oligosialic and polysialic acids: distribution, functions and related disease. J Biochem 154: 115-136. doi: 10.1093/jb/mvt057.
4. Varki NM, Varki A (2007) Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 87: 851-857. doi: 10.1038/labinvest.3700656. (Pubitemid 47267816)
5. Angata T, Varki A (2002) Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 102: 439-470. doi: 10.1021/cr000407m.
6. Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M (2014) Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression. Biochim Biophys Acta. 1840: 2752-2764. doi:10.1016/j.bbagen.
7. Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, et al. (2005) Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res 65: 4645-4652. doi: 10.1158/0008-5472.CAN-04-3117.
8. Almaraz RT, Tian Y, Bhattarcharya R, Tan E, Chen SH, et al. (2012) Metabolic flux increases glycoprotein sialylation: Implications for cell adhesion and cancer metastasis. Mol Cell Proteomics 11: M112.017558. doi: 10.1074/mcp.M112.017558.
9. Park J-J, Yi JY, Jin YB, Lee YJ, Lee JS, et al. (2012) Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol 83: 849-857. doi: 10.1016/j.bcp.2012.01.007.
10. Park JJ, Lee M (2013) Increasing the a2,6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver 7: 629-641. doi: 10.5009/gnl.2013.7.6.629.
11. Lee M, Lee HJ, Bae S, Lee YS (2008) Protein sialylation by sialyltransferase involves radiation resistance. Mol Cancer Res 6: 1316-1325. doi: 10.1158/1541-7786.MCR-07-2209.
12. Angata K, Suzuki M, Fukuda M (1998) Differential and cooperative polysialylation of the neural cell adhesion molecule by two polysialyltransferases, PST and STX. J Biol Chem 273: 28524-28532. doi: 10.1074/jbc.273.43.28524. (Pubitemid 28496160)
13. Hildebrandt H, Mühlenhoff M, Weinhold B, Gerardy-Schahn R (2007) Dissecting polysialic acid and NCAM functions in brain development. J Neurochem 103 Suppl 1: 56-64. doi: 10.1111/j.1471-4159.2007.04716.x.
14. Mühlenhoff M, Rollenhagen M, Werneburg S, Gerardy-Schahn R, Hildebrandt H (2013) Polysialic acid: versatile modification of NCAM, SynCAM 1 and neuropilin-2. Neurochem Res 38: 1134-1143. doi: 10.1007/s11064-013-0979-2.
15. Galuska SP, Rollenhagen M, Kaup M, Eggers K, Oltmann-Norden I, et al. (2010) Synaptic cell adhesion molecule SynCAM 1 is a target for polysialylation in postnatal mouse brain. Proc Natl Acad Sci U S A. 107: 10250-10255. doi: 10.1073/pnas.0912103107.
16. Zhu S, Lee J, Guo F, Shin J, Perez-Atayde AR, et al. (2012) Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 21: 362-373. doi: 10.1016/j.ccr.2012.02.010.
17. Cheung NK, Dyer MA (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13: 397-411.doi: 10.1038/nrc3526.
18. Keppler OT, Horstkorte R, Pawlita M, Schmidt C, Reutter W (2001) Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 11:11R-18R. doi: 10.1093/glycob/11.2.11R. (Pubitemid 32331670)
19. Reuter G, Schauer R (1994) Determination of sialic acids. Methods Enzymol 230: 168-199. doi:10.1016/0076-6879(94)30012-7. (Pubitemid 24080132)
20. Hara S, Takemori Y, Yamaguchi M, Nakamura M, Ohkura Y (1987) Fluorometric high-performance liquid chromatography of N-acetyl-and N-glycolylneuraminic acids and its application to their microdetermination in human and animal sera, glycoproteins, and glycolipids. Anal Biochem 164: 138-145. doi:10.1016/0003- 2697(87)90377-0. (Pubitemid 17099609)
21. Inoue S, Lin SL, Lee YC, Inoue Y (2001) An ultrasensitive chemical method for polysialic acid analysis. Glycobiology 11: 759-767. doi: 10.1093/glycob/11.9.759. (Pubitemid 32976349)
22. Ulm C, Saffarzadeh M, Mahavadi P, Müller S, Prem G (2013) Soluble polysialylated NCAM: a novel player of the innate immune system in the lung. Cell Mol Life Sci 70: 3695-3708. doi: 10.1007/s00018-013-1342-0.
23. Harduin-Lepers A, Mollicone R, Delannoy P, Oriol R (2005) The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology 15: 805-817. doi: 10.1093/glycob/cwi063. (Pubitemid 41417983)
24. Amoureux MC, Coulibaly B, Chinot O, Loundou A, Metellus P, et al. (2010) Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines. BMC Cancer 10: 91. doi: 10.1186/1471-2407-10-91.
25. Valentiner U, Mühlenhoff M, Lehmann U, Hildebrandt H, Schumacher U (2011). Expression of the neural cell adhesion molecule and polysialic acid in human neuroblastoma cell lines. Int J Oncol 39: 417-424. doi: 10.3892/ijo.2011.1038.
26. Martersteck CM, Kedersha NL, Drapp DA, Tsui TG, Colley KJ (1996). Unique alpha 2,8-polysialylated glycoproteins in breast cancer and leukemia cells. Glycobiology 6: 289-301. doi:10.1093/glycob/6.3.289.
27. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, et al. (2012). Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Cancer Res. 61: 1666-1670.
28. Horstkorte R, Mühlenhoff M, Reutter W, Nöhring S, Zimmermann-Kordmann M, et al. (2004). Selective inhibition of polysialyltransferase ST8SiaII by unnatural sialic acids. Exp Cell Res. 298: 268-274. doi:10.1016/j.yexcr.2004.04.014. (Pubitemid 38887326)
29. Bork K, Gagiannis D, Orthmann A, Weidemann W, Kontou M, et al. (2007). Experimental approaches to interfere with the polysialylation of the neural cell adhesion molecule in vitro and in vivo. J Neurochem 103: Suppl 1 65-71. doi: 10.1111/j.1471-4159.2007.04711.x.
30. Chen JY, Tang YA, Huang SM, Juan HF, Wu LW, et al. (2011) A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res 71: 473-483. doi: 10.1158/0008-5472.CAN-10-1303.
31. Campbell CT, Aich U, Weier CA, Wang JJ, Choi SS, et al. (2008) Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. J Med Chem 51: 8135-8147. doi: 10.1021/jm800873k.
32. Komminoth P, Roth J, Saremaslani P, Matias-Guiu X, Wolfe HJ, et al. (1994) Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions. Am J Surg Pathol 18: 399-411. (Pubitemid 24093604)
33. Scheidegger EP, Lackie PM, Papay J, Roth J (1994) In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest. 70: 95-106. (Pubitemid 24080109)